7 Podcast Episodes
Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently
Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently
Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of ... Read more
26 Feb 2021
•
1hr 21mins
A Formula to Help Maximize Your Results and Business Growth in Medical Devices with Duke Rohlen, CEO at Ajax Health
A Formula to Help Maximize Your Results and Business Growth in Medical Devices with Duke Rohlen, CEO at Ajax Health
Leveraging data to drive treatment and physician benefit.For the show notes, full transcript, links, and resources pleas... Read more
20 Jan 2020
•
35mins
Medtech CEO Duke Rohlen Grew Into His Name. Can AJAX Health Do the Same?
Medtech CEO Duke Rohlen Grew Into His Name. Can AJAX Health Do the Same?
In this episode of Medtech Talk, Duke Rohlen, CEO of AJAX Health, answers several critical questions about the importanc... Read more
17 Oct 2019
•
42mins
Duke Rohlen On How His Willingness To Pivot Lead Him To Build And Sell 5 Companies for $1.7 Billion
Duke Rohlen On How His Willingness To Pivot Lead Him To Build And Sell 5 Companies for $1.7 Billion
Serial entrepreneur and venture investor, Duke Rohlen grew up in Marin County, California where he dedicated a significa... Read more
26 Jun 2019
•
44mins
Duke Rohlen On Selling 4 Companies For Over $1 Billion Following These 3 Steps
Duke Rohlen On Selling 4 Companies For Over $1 Billion Following These 3 Steps
Duke Rohlen is a serial entrepreneur. He is the cofounder of FoxHollow Technologies (acquired by Ev3 for $780 million), ... Read more
9 Apr 2019
•
40mins
A Formula to Help Maximize Your Results and Business Growth in Medical Devices with Duke Rohlen, CEO at Ajax Health
A Formula to Help Maximize Your Results and Business Growth in Medical Devices with Duke Rohlen, CEO at Ajax Health
Leveraging data to drive treatment and physician benefit.
12 Sep 2018
•
35mins
After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics
After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics
Jack Dorsey received quite a bit of attention when he was recently announced as CEO of Twitter. Why? Because that made... Read more
31 May 2016
•
40mins